Rainbow trout somatostatin receptor subtypes SSTR1A, SSTR1B, and SSTR2 differentially activate the extracellular signal-regulated kinase and phosphatidylinositol 3-kinase signaling pathways in transfected cells

Journal of Molecular Endocrinology

Volumn 45, Issue 5, 2010, Pages 317-327

  Hagemeister, Alison L ^a   Kittilson, Jeffrey D ^a   Bergan, Heather E ^a   Sheridan, Mark A ^a  

^a NORTH DAKOTA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 MORPHOLINO 8 PHENYLCHROMONE; CCAAT ENHANCER BINDING PROTEIN BETA; GROWTH HORMONE RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PERTUSSIS TOXIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RAF PROTEIN; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; SOMATOSTATIN; SOMATOSTATIN RECEPTOR 1; SOMATOSTATIN RECEPTOR 1A; SOMATOSTATIN RECEPTOR 1B; SOMATOSTATIN RECEPTOR 2; STAT3 PROTEIN; TRANSCRIPTION FACTOR ELK 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CHO CELL; CONTROLLED STUDY; ENZYME ACTIVATION; GENE EXPRESSION; GENETIC TRANSFECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAINBOW TROUT; SIGNAL TRANSDUCTION; TARGET CELL;

ANIMALS; BLOTTING, WESTERN; CHO CELLS; CRICETINAE; CRICETULUS; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION; ONCORHYNCHUS MYKISS; PERTUSSIS TOXIN; PHOSPHATIDYLINOSITOL 3-KINASE; POLYMERASE CHAIN REACTION; RECEPTORS, SOMATOSTATIN; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 78649620519     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1677/JME-10-0046     Document Type: Article

References (48)

1. Buscail L, Estève JP, Saint-Laurent N, Bertrand V, Reisine T, O'Carroll AM, Bell GI, Schally AV, Vaysse N & Susini C 1995 Inhibition of cell proliferation by the somatostatin analogue RC-160 is mediated by somatostatin receptor subtypes SSTR2 and SSTR5 through different mechanisms. PNAS 92 1580-1584. (doi:10.1073/pnas.92.5.1580)
2. Cervia D & Bagnoli P 2007 An update on somatostatin receptor signaling in native systems and new insight on their pathophysiology. Pharmacology and Therapeutics 116 322-341. (doi:10.1016/ j.pharmthera.2007.06. 010)
3. Charland S, Boucher MJ, Houde M & Rivard N 2001 Somatostatin inhibits Akt phosphorylation and cell cycle entry, but not p42/p44 mitogen-activated protein (MAP) kinase activation in normal and tumoral pancreatic acinar cells. Endocrinology 142 121-128. (doi:10.1210/en.142.1.121)
4. Chung J, Uchida E, Grammer TC & Blenis J 1997 Stat3 serine phosphorylation by ERK-dependent and independent pathways negatively modulates its tyrosine phosphorylation. Molecular and Cellular Biology 17 6508-6516.
5. Cui TX, Kwok R & Schwartz J 2008 Cooperative regulation of endogenous cAMP-response element binding protein and CCAAT/enhancer-binding protein beta in GH-stimulated c-fos expression. Journal of Endocrinology 196 89-100. (doi:10.1677/ JOE-07-0169)
6. Florio T, Rim C, Hershberger RE, Loda M & Stork PJ 1994 The somatostatin receptor SSTR1 is coupled to phosphotyrosine phosphatase activity in CHO-K1 cells. Molecular Endocrinology 8 1289-1297. (doi:10.1210/me.8.10.1289)
7. Florio T, Thellung S, Arena S, Corsaro A, Spaziante R, Gussoni G, Acuto G, Giusti M, Giordano G & Schettini G 1999 Somatostatin and its analog lanreotide inhibit the proliferation of dispersed human non-functioning pituitary adenoma cells in vitro. European Journal of Endocrinology 141 396-408. (doi:10.1530/eje.0.1410396)
8. Florio T, Thellung S, Arena S, Corsaro A, Bajetto A, Schettini G & Stork PJ 2000 Somatostatin receptor 1 (SSTR1)-mediated inhibition of cell proliferation correlates with the activation of the MAP kinase cascade: role of the phosphotyrosine phosphatase SHP-2. Journal of Physiology 94 239-250. (doi:10.1016/S0928- 4257(00)00214-X)
9. Gahete MD, Duran-PradoM, Luque RM, Martinez-Fuentes R, Vazquez- Martinez MM, Malagon MM & Castano JP 2008 Are somatostatin and cortistatin two siblings in regulating endocrine secretions? In vitro work ahead Molecular and Cellular Endocrinology 286 128-134. (doi:10.1016/j.mce.2007.11.013)
10. Gahete MD, Cordoba-Chacon J, Duran-Prado M, Malagon MM, Martinez-Fuentes AJ, Gracia-Navarro F, Luque RM & Castano JP 2010 Somatostatin and its receptors from fish to mammals. Annals of the New York Academy of Sciences 1200 43-52. (doi:10.1111/j.1749- 6632.2010.05511.x)
11. Ghosh S, Choritz L, Geibel J & Coca-Prados M 2006 Somatostatin modulates PI3K-Akt, eNOS and NHE activity in the ciliary epithelium. Molecular and Cellular Endocrinology 253 63-75. (doi:10.1016/j.mce.2006.05.002) (Pubitemid 43946572)
12. Gong JY, Kittilson JD, Slagter BJ & Sheridan MA 2004 The two subtype 1 somatostatin receptors of rainbow trout, Tsst1A and Tsst1B, possess both distinct and overlapping ligand binding and agonist-induced regulation features. Comparative Biochemistry and Physiology, Part B 138 295-303. (doi:10.1016/j.cbpc.2004.04.005)
13. Hagemeister AL & Sheridan MA 2008 Somatostatin inhibits hepatic growth hormone receptor and insulin-like growth factor I mRNA expression by activating the ERK and PI3K signaling pathways. American Journal of Physiology 295 R490-R497. (doi:10.1152/ajpcell. 00188.2008)
14. Hanson A, Poudyal D, Hagemeister A, Reindl KM & Sheridan MA 2010 The ERK and PI3K signaling pathways mediate inhibition of insulin-like growth factor-1 receptor mRNA expression by somatostatin. Molecular and Cellular Endocrinology 315 57-62. (doi:10.1016/j.mce. 2009.09.034)
15. Hukovic N, Panetta R, Kumar U, Rocheville M & Patel YC 1998 The cytoplasmic tail of the human somatostatin receptor type five is crucial for interaction with adenylyl cyclase and in mediating desensitization and internalization. Journal of Biological Chemistry 273 21416-21422. (doi:10.1074/jbc.273.33.21416)
16. Klein SE & Sheridan MA 2008 Somatostatin signaling and the regulation of growth and metabolism in fish. Molecular and Cellular Endocrinology 286 148-154. (doi:10.1016/j.mce.2007.08.010)
17. Lahlou H, Saint-Laurent N, Esteve JP, Eychene A, Pradayrol L, Pyronnet S & Susini C 2003 sst2 Somatostatin receptor inhibits cell proliferation through Ras-, Rap1-, and B-Raf-dependent ERK2 activation. Journal of Biological Chemistry 278 39356-39371. (doi:10. 1074/jbc.M304524200)
18. Lin X & Peter RE 2001 Somatostatins and their receptors in fish. Comparative Biochemistry and Physiology, Part B 129 543-550. (doi:10.1016/S1096-4959(01)00362-1)
19. Lin X, Janovik J, Brothers S, Conn PP & Peter RE 1999 Molecular cloning and expression of two type one somatostatin receptors in goldfish brain. Endocrinology 140 5211-5219. (doi:10.1210/en.140. 11.5211)
20. 14 and multiple signaling components: a mechanism requiring protein kinase C, calmodulin-dependent kinase II, ERK, and c-Src. Journal of Biological Chemistry 80 34617-34625. (doi:10. 1074/jbc.M504264200)
21. 5 in BON-1 cells. Medical Oncology 21 285-296. (doi:10.1385/MO:21:3:285)
22. Moller LN, Stidsen CE, Hartmann C & Holst JJ 2003 Somatostatin receptors. Biochimica et Biophysica Acta 1616 1-84. (doi:10.1016/ S0005-2736(03)00235-9)
23. Murray RD, Kim K, Ren SG, Chelly M, Umehara Y & Melmed S 2004 Central and peripheral actions of somatostatin on the growth hormone-IGF-1 axis. Journal of Clinical Investigation 114 349-356. (doi:10.1172/JCI19933)
24. Nelson LE & Sheridan MA 2005 Regulation of somatostatins and their receptors in fish. General and Comparative Endocrinology 142 117-133. (doi:10.1016/j.ygcen.2004.12.002)
25. Pesek MJ, Howe N & Sheridan MA 1998 Somatostatin binding to hepatocytes isolated from rainbow trout, Oncoryhnchus mykiss, is modulated by insulin and glucagon. General and Comparative Endocrinology 112 183-190. (doi:10.1006/gcen.1998.7154) (Pubitemid 28516173)
26. Reusch HP, Zimmermann S, Schaefer M, Paul M & Moelling K 2001 Regulation of Raf by Akt controls growth and differentiation in vascular smooth muscle cells. Journal of Biological Chemistry 276 33630-33637. (doi:10.1074/jbc.M105322200)
27. Schrem H, Klempnauer J & Borlak J 2004 Liver-enriched transcription factors in liver function and development. Part II: the C/EBPs and D site-binding protein in cell cycle control, carcinogenesis, circadian gene regulation, liver regeneration, apoptosis, and liver-specific gene regulation. Pharmacological Reviews 56 291-330. (doi:10.1124/pr.56.2.5)
28. Schwartzbauer G & Menon RK 1998 Regulation of growth hormone receptor gene expression. Molecular Genetics and Metabolism 63 243-253. (doi:10.1006/mgme.1998.2685) (Pubitemid 28455901)
29. Sheridan MA & Hagemeister AL 2010 Somatostatin and somatostatin receptors in fish growth. General and Comparative Endocrinology 167 360-365. (doi:10.1016/j.ygcen.2009.09.002)
30. Sheridan MA, Kittilson JD & Slagter BA 2000 Structure-function relationships of the somatostatin peptide hormone family. American Zoologist 40 269-286. (doi:10.1668/0003- 1569(2000)040[0269:SFROTS]2.0.CO;2)
31. Siehler S, Nunn C, Zupanc GK & Hoyer D 2005 Fish somatostatin sst3 receptor: comparison of radioligand and GTPgammaS binding, adenylate cyclase and phospholipase C activities reveals different agonist-dependent pharmacological signatures. Autonomic and Autacoid Pharmacology 25 1-16. (doi:10.1111/j.1474- 8673.2004. 00325.x)
32. Siehler S, Nunn C, Hannon J, Feuerbach D & Hoyer D 2008 Pharmacological profile of somatostatin and cortistatin receptors. Molecular and Cellular Endocrinology 286 26-34. (doi:10.1016/j.mce.2007.12.007)
33. Siriwardana G, Bradford A, Coy D & Zeitler P 2006 Autocrine/paracrine regulation of breast cancer cell proliferation by growth hormone releasing hormone via Ras, Raf, and mitogen-activated protein kinase. Molecular Endocrinology 20 2010-2019. (doi:10.1210/ me.2005-0001)
34. Slagter BJ & Sheridan MA 2004 Differential expression of two somatostatin receptor subtype 1 mRNAs in rainbow trout (Oncorhynchus mykiss). Journal of Molecular Endocrinology 32 165-177. (doi:10.1677/jme.0.0320165)
35. Stetak A, Csermely P, Ullrich A & Keri G 2001 Physical and functional interactions between protein tyrosine kinase phosphatase alpha, PI3-kinase, and PKCdelta. Biochemical and Biophysical Research Communications 288 564-572. (doi:10.1006/ bbrc.2001.5811)
36. Stirnweis J, Boehmer FD & Liebmann C 2002 The putative somatostatin antagonist, cyclo-(7-aminoheptanoyl-Phe-D-Trp-Lys- Thr{BZL}0, may act as potent antiproliferative agonist. Peptides 23 1503-1506. (doi:10.1016/S0196-9781(02) 00089-X)
37. Tanel A & Averill-Bates DA 2007 P38 and ERK mitogen activated protein kinases mediate acrolein-induced apoptosis in Chinese hamster ovary cells. Cellular Signalling 19 968-977. (doi:10.1016/ j.cellsig.2006.10.014)
38. Theodoropoulou M, Zhang J, Laupheimer S, Paez-Pereda M, Erneux C, Florio T, Pagotto U & Stalla GK 2006 Octreotide, a somatostatin analogue, mediates its antiproliferative action in pituitary tumor cells by altering phosphatidylinositol 3-kinase signaling and inducing Zacd1expression. Cancer Research 66 1576-1582doi:10.1158/0008-5472.CAN-05-1189) (Pubitemid 43259940)
39. Tostivint H, Lihrmann I & Vaudry H 2008 New insights into the molecular evolution of the somatostatin family. Molecular and Cellular Endocrinology 286 5-17. (doi:10.1016/j.mce.2008.02.029)
40. Turjanski AG, Vaqué JP & Gutkind JS 2007 MAP kinases and the control of nuclear events. Oncogene 26 3240-3253. (doi:10.1038/ sj.onc.1210415)
41. Valatas V, Kolios G, Manousou P, Xidakisc C, Notas G, Ljumovic D & Kouroumalis EA 2004 Secretion of inflammatory mediators by isolated rat Kupffer cells: the effect of octreotide. Regulatory Peptides 120 215-225. (doi:10.1016/j.regpep.2004.03.009)
42. Van Op den bosch J, Adriaensen D, Van Nassauw L & Timmermans J-P 2009 The role(s) of somatostatin, structurally related peptides and somatostatin receptors in the gastrointestinal tract: a review. Regulatory Peptides 156 1-8. (doi:10.1016/j.regpep.2009.04.003)
43. Wang Y & Jiang H 2005 Identification of a distal STAT5-binding DNA region that may mediate growth hormone regulation of insulin-like growth factor I gene expression. Journal of Biological Chemistry 280 10955-10963. (doi:10.1074/jbc.M412808200) (Pubitemid 40418397)
44. Wood AW, Duan C & Bern HA 2005 Insulin-like growth factor signaling in fish. International Reviews of Cytology 243 215-285. (doi:10.1016/S0074- 7696(05)43004-1)
45. Yart A, Roche S,Wetzker R, LaffargueM, Tonks N,Mayeux P, Chap H& Raynal P 2002 A function for phosphoinositide 3-kinase beta lipid products in coupling beta gamma to Ras activation in response to lysophosphatidic acid. Journal of Biological Chemistry 277 21167-21178. (doi:10.1074/jbc.M110411200)
46. Yoshitomi H, Fujii Y, Miyazaki M, Nakajima N, Inagaki N & Seino S 1997 Involvement of MAP kinase and c-fos signaling in the inhibition of cell growth by somatostatin. American Journal of Physiology 272 E769-E774.
47. Yunker WK, Smith S, Graves C, Davis PJ, Unniappan S, Rivier JE, Petrer RE & Chang JP 2003 Endogenous hypothalamic somatostatins differentially regulate growth hormone secretion from goldfish pituitary somatotropes in vitro. Endocrinology 144 4031-4041. (doi:10.1210/en.2003-0439) (Pubitemid 37088758)
48. Zimmermann S & Moelling K 1999 Phosphorylation and regulation of Raf by Akt (protein kinase B). Science 286 1741-1744. (doi:10.1126/ science.286.5445.1741)